Insider · CIK 0001846836
Ouzren Nawal
Reports to the SEC for 1 company · SAN DIEGO, CA
Transactions
11
Companies
1
Filings
3
CIK
0001846836
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-03-11 | ARENA PHARMACEUTICALS INCJ Other | — |
| 2022-03-11 | ARENA PHARMACEUTICALS INCJ Other | — |
| 2022-03-11 | ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer | — |
| 2022-03-11 | ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer | — |
| 2022-03-11 | ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer | — |
| 2021-06-11 | ARENA PHARMACEUTICALS INCA Award | — |
| 2021-06-11 | ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
| 2021-02-12 | ARENA PHARMACEUTICALS INCA Award | — |
| 2021-02-12 | ARENA PHARMACEUTICALS INCA Award | — |
| 2021-02-12 | ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
| 2021-02-12 | ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award | — |
Recent filings
- 4Ouzren Nawal0001628280-22-005906SEC(opens sec.gov)
- 4Ouzren Nawal0001628280-21-012280SEC(opens sec.gov)
- 4Ouzren Nawal0001209191-21-012209SEC(opens sec.gov)
Companies
Address
C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE
SAN DIEGO, CA, 92121